AMA CPT® Assistant - 2017 Issue 3 (March)
Presumptive Drug Class Screening Changes (March 2017)
March 2017 page 6 Presumptive Drug Class Screening Changes Important updates and revisions were made to the Pathology and Laboratory section of the Current Procedural Terminology (CPT®) 2017 code set. Because there is a significant amount of information to provide, this topic will be broken down into separate articles in 2017. In this first installment, we discuss the changes in the Presumptive Drug Class Screening (PDCS) code subsection. Future articles will discuss changes in the Multianalyte Assays with Algorithmic Analyses (MAAAs) subsection, changes to the molecular pathology sections of CPT, including changes in the Genomic Sequencing Procedures, and...
Subscribe or sign in to view the full article.
Article Overview
This article explains a March 2017 update to the CPT Pathology and Laboratory section focused on presumptive drug class screening. It is aimed at coders, billers, laboratory personnel, and compliance staff who need to understand what changed in the code subsection, how the revised guidance is organized, and how the new structure relates to the broader 2017 CPT laboratory revisions.
Why This Topic Matters
The update affects how presumptive drug screening services are categorized in CPT 2017 and highlights the transition from deleted codes to revised reporting structure. Understanding the scope of the changes helps users identify whether the article is relevant to laboratory coding workflows and CPT update review.
Article Sections
-
March 2017 page 6
Introductory context for the CPT 2017 Pathology and Laboratory updates and the planned series of related articles.
-
Presumptive Drug Class Screening
Overview of the changes made to the presumptive drug class screening subsection, including deleted and newly added codes and the revised guideline framework.
-
New Codes
Presentation of the revised code set and related reference information for the presumptive drug screening subsection.
-
Clinical Example (80305)
A clinical scenario and associated procedure description illustrating one category of presumptive drug screening.
-
Clinical Example (80306)
A clinical scenario and associated procedure description illustrating another category of presumptive drug screening.
-
Clinical Example (80307)
A clinical scenario and associated procedure description illustrating a higher-complexity category of presumptive drug screening.
What You Will Learn
- How the March 2017 CPT article organizes updates to presumptive drug class screening
- Which parts of the CPT laboratory section are discussed in this installment
- What types of material are covered in the new and deleted code discussion
- How the article frames the related clinical examples and procedure descriptions
- How the update fits into a broader series of 2017 CPT laboratory articles
Who Should Read This
- Medical coders
- Laboratory coders
- Billing staff
- Compliance professionals
- Pathology and laboratory personnel
- Revenue cycle teams
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com